临床试验/NL-OMON50502

NL-OMON50502

已完成

3 期

A randomized placebo-controlled study in patients with a Gallium-68 DOTATATE PET/CT positive, clinically non-functioning pituitary macroadenoma (NFMA) of the effect of Lanreotide autosolution on Tumor (adenoma) size - GALANT

Academisch Medisch Centrum0 个研究点目标入组 66 人待定

适应症pituitary adenoma pituitary tumor 10021112 10014710

概览

阶段: 3 期
干预措施: 未指定
疾病 / 适应症: pituitary adenoma
发起方: Academisch Medisch Centrum
入组人数: 66
状态: 已完成
最后更新: 2年前

概览研究者入排标准结局指标相似试验

概览

简要总结

暂无简介。

注册库

who.int

开始日期

待定

结束日期

待定

最后更新

2年前

研究类型

Interventional

研究者

发起方

Academisch Medisch Centrum

入排标准

入选标准

•\* Clinically non\-functioning pituitary macroadenoma, or post\-surgical
•residue/recurrence \>\<\= 10mm, with suprasellar extension

排除标准

•\* Optic chiasm compression and/or visual field defects
•\* Hypersensitivity for somatostatin or similar peptides
•\* Obstructive neuroendocrine gut tumor
•\* Symptomatic cholelithiasis
•\* Use of dopamine agonists in the past 6 months
•\* Use of somatostatin analogues in the past 6 months
•\* Pregnancy (plans)
•\* Any contraindication to perform MRI with gadolinium based contrast agent
•(including implanted metallic devices, impaired renal function and severe
•claustrophobia)

结局指标

主要结局

未指定

相似试验

进行中（未招募）

The effect of lanreotide on non-functioning pituitary macroadenoma size

EUCTR2015-001234-22-NLAcademic Medical Center66

Improving outcomes for the upper limb in severe stroke: the efficacy of rehabilitation interventions based on the Bobath concept - a pilot studyStrokeStroke - HaemorrhagicStroke - Ischaemic

ACTRN12609000970246St Vincent's Hospital62

Clinical Study to Evaluate the Efficacy and Safety in Healthy Adults for a period of 2 months for the safety endpoints.

CTRI/2024/05/066815Herbal Creations

Clinical study on the effect of Navayas Lauha (an ayurvedic classical formulation) and specific diet in the management of obesity(sthaulya)

CTRI/2024/02/062731G J Patel Institute of Ayurvedic Studies and Research

进行中（未招募）

A randomized placebo-controlled clinical trial of topical photodynamic therapy with a nanoemulsion formulation of 5-aminolevulinic acid for the treatment of actinic keratosis

EUCTR2006-000314-20-DEBiofrontera Bioscience GmbH260